Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together
- Sponsor
- Boehringer Ingelheim
- Study ID
- NCT01811953
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- Empagliflozin — DRUGmedium dose oral administration
- Metformin — DRUGoral administration
- Empagliflozin — DRUGlow dose of Empagliflozin oral administration
- Empagliflozin/Metformin — DRUGlow dose of Empagliflozin
- Metformin — DRUGoral administration
- Empagliflozin/Metformin — DRUGmedium dose of Empagliflozin oral administration
- Empagliflozin — DRUGmedium dose oral administration
- Metformin — DRUGoral administration
- Empagliflozin/Metformin — DRUGmedium dose of Empagliflozin oral administration
Study Details
Bioequivalence of an empagliflozin/metformin (FDC) tablet compared with single tablets of two strength of empagliflozin and metformin (Part I) under fasted and under fed conditions and bioequivalence of empagliflozin/metformin (FDC) tablet compared with single tablets empagliflozin and metformin under fed conditions (Part II).
Key Dates
- Start date
- Mar 31, 2013
- Status verified
- Jun 2015
- Primary completion
- May 31, 2013
- Completion
- May 31, 2013
Study Design
- Enrollment
- 48 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: 1 Empagliflozin/Metformin (T)fixed-dose-combination tablet, oral with 240 ml water under fasted conditions
- Experimental: 2 Empagliflozin/Metformin (T)fixed-dose-combination tablet, oral with 240 ml water under fed conditions
- Experimental: 3 Empagliflozin + Metformin (R)tablets, oral with 240 ml water under fasted conditions
- Experimental: 4 Empagliflozin + Metformin (R)tablets, oral with 240 ml water under fed conditions
- Experimental: 5 Empagliflozin/Metformin (T)fixed-dose-combination tablet, oral with 240 ml water under fed conditions
- Experimental: 6 Empagliflozin + Metformin (R)tablets, oral with 240 ml water under fed conditions
Primary Outcome Measure
Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 Extrapolated to Infinity, Empagliflozin [ Time Frame: 1 hour (h) before first drug administration and 20 minutes (min), 40min, 1h, 1h 30min, 2h, 2h 30min, 3h, 3h 30 min, 4h, 5h, 6h, 8h, 10h, 12h, 24h, 34h, 48h and 72h after drug administration ]
Related Studies
- Study of New Magnetic Resonance Imaging Methods of the BrainRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Mapping Auricular Vagus Nerve CircuitryEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group TestingRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Evaluation and Optimization of Ultrasound and/or MRI Hardware and SoftwareRecruiting · State University of New York - Upstate Medical University · Syracuse, New York